Substituted heterocycles

Details for Australian Patent Application No. 2004212296 (hide)

Owner InterMed Discovery GmbH

Inventors Bruning, Michael-Alexander; Bacon, Kevin; Stadler, Marc; Fuchikami, Kinji; Dodo, Reiko; Mayer-Bartschmid, Anke; Reinemer, Peter; Matsukawa, Satoko; Muller, Hartwig; Togame, Hiroko; Urbahns, Klaus; Benet-Buchholz, Jordi; Seip, Stephan

Agent Davies Collison Cave

Pub. Number AU-B-2004212296

PCT Pub. Number WO2004/071382

Priority 03003495.3 14.02.03 EP; 03007594.9 02.04.03 EP

Filing date 6 February 2004

Wipo publication date 26 August 2004

Acceptance publication date 17 June 2010

International Classifications

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61P 35/00 (2006.01) Antineoplastic agents

C07D 207/277 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C12P 17/10 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - Nitrogen as only ring hetero atom

C12P 17/18 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

C07D 207/26 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C12R 1/465 (2006.01)

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/071382 Priority application(s): WO2004/071382

31 August 2006 Assignment before Grant

  Bayer HealthCare AG The application has been assigned to InterMed Discovery GmbH

17 June 2010 Application Accepted

  Published as AU-B-2004212296

14 October 2010 Standard Patent Sealed

30 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212297-The use of lupin conglutin for the treatment of type II diabetes

2004212280-Extraction module with linear closure for the pressurised preparation of a drink from a capsule